Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Does ovarian follicle depletion after menopause cause lower estradiol and higher FSH?

Exhaustion of the ovarian follicle reserve reduces estradiol and inhibin B, removing negative feedback on the pituitary and resulting in chronically elevated FSH levels.

SupportedJune 19, 202614 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

After menopause, ovarian follicle depletion reduces estradiol production and removes negative feedback on the pituitary, leading to elevated follicle-stimulating hormone.

laying out figure…
All 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that menopause results from depletion of the ovarian follicular pool, which sharply lowers granulosa cell–dependent estradiol production. The mechanism explains that loss of estradiol and inhibin B disrupts hypothalamic–pituitary negative feedback, permitting sustained increases in pituitary FSH secretion.

Verified conclusion

The transition into menopause is fundamentally driven by the exhaustion of the ovarian follicular reserve, which disrupts the endocrine signaling of the hypothalamic-pituitary-ovarian (HPO) axis.

Clinical and Physiological Findings

Menopause occurs when the primordial follicle pool, which contains approximately 700,000 follicles at birth, is depleted to a threshold of fewer than 1,000 follicles. This depletion is a primary driver of the systemic changes observed in a 57-year-old patient:

  • Estradiol Decline: The loss of follicles leads to a sharp reduction in cyclic estradiol. Granulosa cells within growing follicles are the primary source of this hormone. In aging ovaries, studies have shown granulosa cell apoptosis rates as high as 87%, compared to roughly 26% in younger controls, effectively halting the ovary's capacity for significant steroidogenesis.
  • FSH Elevation: The clinical hallmark of menopause is a hypergonadotropic state, where follicle-stimulating hormone (FSH) levels are chronically elevated. This is not due to an overactive pituitary, but rather the removal of the inhibitory signals that normally keep FSH in check.

Mechanistic Pathways

The elevation of FSH is the result of the loss of two distinct negative feedback loops:

  • Loss of Inhibin B: Produced by the granulosa cells of small follicles, inhibin B is often the first signal to decline. It provides selective negative feedback directly to the pituitary to suppress FSH synthesis. As follicle numbers drop, inhibin B levels fall, allowing FSH to rise even before estradiol levels significantly fluctuate.
  • Estradiol Feedback: Estradiol exerts negative feedback on both the hypothalamus (regulating GnRH pulse frequency) and the pituitary gland through Estrogen Receptor alpha (ERα) signaling. The depletion of follicles removes this "brake" on the system, leading to the sustained increase in FSH secretion.

Bottom line

The claim is strongly supported by established reproductive endocrinology. Ovarian follicle depletion directly results in the loss of estradiol and inhibin B, which removes the necessary negative feedback on the pituitary, causing the elevated FSH levels characteristic of the postmenopausal state.

References

  1. Modelling Menopause Age with Emphasis on the Relationship Between Age, Non-Growing Follicles and Ovarian Depletion — ejtas.com ↗
  2. Stochastic Analysis of Human Ovarian Aging and Menopause Timing. — linkinghub.elsevier.com ↗
  3. Genetics of the ovarian reserve — pmc.ncbi.nlm.nih.gov ↗
  4. The menopause and aging, a comparative perspective — pmc.ncbi.nlm.nih.gov ↗
  5. Reproductive hormones and the menopause transition. — pmc.ncbi.nlm.nih.gov ↗
  6. Menopause and hypothalamic-pituitary sensitivity to estrogen. — jama.jamanetwork.com ↗
  7. Molecular mechanisms regulating natural menopause in the female ovary: a study based on transcriptomic data — frontiersin.org ↗
  8. Astragalin, a Flavonoid from Morus alba (Mulberry) Increases Endogenous Estrogen and Progesterone by Inhibiting Ovarian Granulosa Cell Apoptosis in an Aged Rat Model of Menopause — mdpi.com ↗
  9. The Hypothalamic-Pituitary-Ovarian Axis, Ovarian Disorders, and Brain Aging — academic.oup.com ↗
  10. Classical estrogen receptor alpha signaling mediates negative and positive feedback on gonadotropin-releasing hormone neuron firing. — pmc.ncbi.nlm.nih.gov ↗
  11. Dysregulation of hypothalamic‐pituitary estrogen receptor α–mediated signaling causes episodic LH secretion and cystic ovary — pmc.ncbi.nlm.nih.gov ↗
  12. Estrogen negative feedback on gonadotropin secretion: evidence for a direct pituitary effect in women. — pmc.ncbi.nlm.nih.gov ↗
  13. Age-associated up-regulation of EGR1 promotes granulosa cell apoptosis during follicle atresia in mice through the NF-κB pathway — pmc.ncbi.nlm.nih.gov ↗
  14. Novel Ovarian Regulatory Peptides: Inhibin, Activin, and Follistatin — journals.lww.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→